Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMGEN INC

  • FDA Approval
  • Aug. 26, 2024, 10:06 UTC
  • 63
  • 0 comments

FDA approve AFLIBERCEPT

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 49
  • 0 comments

FDA approve PRAZIQUANTEL

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 56
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

AMNEAL

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 51
  • 0 comments

FDA approve ISOPROTERENOL HYDROCHLORIDE

Comment Full text

ONY

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 54
  • 0 comments

FDA approve CALFACTANT

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 46
  • 0 comments

FDA approve TADALAFIL

Comment Full text

PRINSTON INC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 51
  • 0 comments

FDA approve PREGABALIN

Comment Full text

MYLAN

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 43
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

RISING

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 52
  • 0 comments

FDA approve PENTOSTATIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 39
  • 0 comments

FDA approve NATEGLINIDE

Comment Full text
  • Previous
  • 367
  • 368
  • 369
  • 370
  • 371
  • Next

Search

News categories

  • Technical Exchange News(14657)
  • Event(6229)
  • SEC News(390625)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238047)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin